Renexxion Ireland Ltd. Announces Issuance of Fifth New U.S. Patent Covering Novel Crystal Isoform of Naronapride
26 nov. 2024 08h00 HE
|
RENEXXION IRELAND
Renexxion Ireland Ltd marks a major milestone in its intellectual property portfolio.